Aptamer selection and applications for breast cancer diagnostics and therapy

Table 1 Aptamers specific for breast cancer

Aptamer	Sequence (5′–3′)	Target	References
H2	GGGCCGTCGAACACGAGCATGGTGCGTGGACCTAGGATGACCTGAGTACTGTCC	HER2	[40]
AS1411	GGTGGTGGTGGTTGTGGTGGTGGTGG	Nucleolin	[41, 42]
ERaptD4	ATACCAGCTTATTCAATTCGTTGCATTTAGGTG CATTACGGGGGTTATCCGCTCTCTCAGATAGTA TGTGCAATCA	ERα	[43]
S6	TGGATGGGGAGATCCGTTGAGTAAGCGGGCGTGTCTCTCTGCCGCCTTGCTATGGGG	SK-BR-3 cells	[44]
XLX-1-A	GAATTCAGTCGGACAGCGAAGTAGTTTTCCTT CTAACCTAAGAACCCGCGGCAGTTTAATGTAG ATGGACGAA	MDA-MB-231 cells	[45]
MUC1	GCAGTTGATCCTTTGGATACCCTGG	Mucin-1	[46]
HB5	AACCGCCCAAATCCCTAAGAGTCTGCACTTGT CATTTTGTATATGTATTTGGTTTTTGGCTCTCAC AGACACACTACACACGCACA	HER2	[47]
KMF2-1a	AGGCGGCAGTGTCAGAGTGAATAGGGGATGTA CAGGTCTGCACCCACTCGAGGAGTGACTGAGCGACGAAGACCCC	MCF-10AT1 cells	[48]
SYL3C	CACTACAGAGGTTGCGTCTGTCCCACGTTGTCATGGGGGGTTGGCCTG	EpCAM	[49]

ISSN: 1477-3155